A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Gibb A, Greystoke A, Ranson M, Linton K, Neeson S, Hampson G, Illidge T, Smith E, Dive C, Pettitt A, Lister A, Johnson P, Radford J

Publication type: Article

Publication status: Published

Journal: British Journal of Cancer

Year: 2013

Volume: 109

Issue: 10

Pages: 2560-2565

Print publication date: 12/11/2013

Online publication date: 17/10/2013

Acceptance date: 11/09/2013

ISSN (print): 0007-0920

ISSN (electronic): 1532-1827

Publisher: Nature Publishing Group

URL: http://dx.doi.org/10.1038/bjc.2013.605

DOI: 10.1038/bjc.2013.605

Altmetrics provided by Altmetric

ePrints